Posts by: Alice Melão

News

The European Medicines Agency (EMA) has granted Priority Medicine (PRIME) designation to Roche’s investigational therapy RG6042 for the treatment of Huntington’s disease. PRIME provides a pathway for expedited assessment ... Read more

July 25, 2018

Phase 2a Trial Investigates BP Medicine SOM3355 as Treatment for Chorea

News

SOM3355 — a medicine approved for high blood pressure and chest pain — is being tested in a Phase 2 trial as a means to treat chorea in Huntington’s disease patients, SOM ... Read more

July 10, 2018July 10, 2018

Improved Genetic Testing Protocols Should be Available for Huntington’s Disease, Study Contends

News

Adequate support and follow-up should be considered when implementing and designing pre-symptomatic genetic testing for Huntington’s disease, a study has revealed. The study, “Perspectives on Genetic Testing and Return ... Read more

June 28, 2018June 28, 2018

Experts Seeking Tools to Assess Effectiveness of Targeted Huntington’s Therapies

News

Improved measures to accurately determine the effectiveness of treatments targeting Huntington’s disease are necessary, according to clinical neurologists and Huntington’s specialists. The editorial, “Improved metrics for Huntington’s disease trials,” ... Read more

June 21, 2018June 21, 2018

New Huntingtin Protein Strategy Significantly Improves Symptoms Over Time, Study Finds

Huntington's Disease News, News

A new therapeutic strategy based on a small part of the huntingtin protein — which in a mutated form is responsible for Huntington’s disease — shows potential to regulate ... Read more

May 29, 2018May 29, 2018

Apathy Linked to Physical, Cognitive and Behavioral Disability in Huntington’s Patients, Study Finds

News

Apathy is linked to physical, cognitive, and behavioral impairments in patients with Huntington’s disease, a study shows. The study, “Relationships Among Apathy, Health-Related Quality of Life, and Function in ... Read more

April 17, 2018April 17, 2018

#AAN2018 – IONIS-HTTRx Shows Promise in Phase 1/2 Trial to Treat Early-stage Huntington’s

News

The investigative therapy IONIS-HTTRx effectively reduced levels of the protein responsible for Huntington’s disease in early-stage patients, according to the findings of an ongoing Phase 1/2 clinical trial. The results ... Read more

April 10, 2018April 10, 2018

HTT Mutations Seen to Cause Extensive Brain Remodeling, Affecting Motor and Cognitive Skills

News

Mutations linked to Huntington’s disease cause more extensive remodeling of functional connectivity in various regions of the brain than previously thought, affecting patients’ motor and cognitive skills, research looking ... Read more

March 20, 2018March 20, 2018

New Version of Genome Editing System Holds Potential to Treat Huntington’s

News

A modified version of the genome-editing CRISPR-Cas9 system may prevent the production of faulty huntingtin protein, moving closer to treatment for Huntington’s disease. The study, “Precise Excision of the ... Read more

February 27, 2018February 27, 2018

Huntington’s Patients’ Skin Cells Transformed Into Nerve Cells That Mimic Disease Symptoms

News

Nerve cells that mimic the molecular features of Huntington’s disease have been created from patients’ skin cells, researchers said. The study, “Striatal neurons directly converted from Huntington’s disease patient ... Read more

Posts by: Alice Melão

Alice Melão

PRIME Designation Should Help Promising Experimental Therapy Reach Huntington’s Patients Faster

Phase 2a Trial Investigates BP Medicine SOM3355 as Treatment for Chorea

Improved Genetic Testing Protocols Should be Available for Huntington’s Disease, Study Contends

Experts Seeking Tools to Assess Effectiveness of Targeted Huntington’s Therapies

New Huntingtin Protein Strategy Significantly Improves Symptoms Over Time, Study Finds

#AAN2018 – IONIS-HTTRx Shows Promise in Phase 1/2 Trial to Treat Early-stage Huntington’s

HTT Mutations Seen to Cause Extensive Brain Remodeling, Affecting Motor and Cognitive Skills

New Version of Genome Editing System Holds Potential to Treat Huntington’s

Huntington’s Patients’ Skin Cells Transformed Into Nerve Cells That Mimic Disease Symptoms

Pin It on Pinterest